Manufacture/Marketer: Boehringer Ingelheim India Pvt. Ltd.
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Trajenta Duo 2.5/850 mg Tablet is a prescription medication specifically designed for the management of type 2 diabetes mellitus. This pharmaceutical product combines two active ingredients: Linagliptin and Metformin. Linagliptin is a DPP-4 inhibitor that works by increasing the levels of incretin hormones, which in turn helps to regulate blood sugar levels by stimulating insulin secretion and reducing glucagon secretion. Metformin, on the other hand, is a biguanide that primarily decreases hepatic glucose production and enhances insulin sensitivity in peripheral tissues. The combination of these two agents in Trajenta Duo 2.5/850 mg Tablet provides a synergistic effect, making it an effective option for patients who require better glycemic control. The tablet is typically prescribed when diet and exercise alone have not been sufficient to control blood sugar levels. It is important to note that Trajenta Duo 2.5/850 mg Tablet is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis. The formulation is available in a convenient tablet form, allowing for easy administration and adherence to treatment regimens. Patients using Trajenta Duo 2.5/850 mg Tablet should be monitored regularly for efficacy and safety, as with any diabetes medication, to ensure optimal management of their condition.
Uses & Benefits
Helps in controlling blood sugar levels in adults with type 2 diabetes.
Reduces the risk of diabetes-related complications.
Improves glycemic control when used alongside diet and exercise.
Combines the benefits of Linagliptin and Metformin for enhanced efficacy.
May lead to weight stabilization or modest weight loss compared to other diabetes medications.
Can be used in conjunction with other antidiabetic medications if needed.
How Trajenta Duo 2.5/850 mg Tablet works
Linagliptin increases incretin levels, leading to increased insulin secretion from the pancreas.
It decreases glucagon secretion, which reduces glucose production by the liver.
Metformin decreases hepatic glucose output and enhances insulin sensitivity in muscle and fat tissues.
The combination helps to lower blood glucose levels effectively.
Both components work together to provide better overall glycemic control.
How to use Trajenta Duo 2.5/850 mg Tablet
Take Trajenta Duo 2.5/850 mg Tablet orally with or without food, as directed by your healthcare provider.
The usual starting dose is one tablet taken once daily.
Dosage may be adjusted based on individual response and blood glucose levels.
Do not exceed the prescribed dosage without consulting your doctor.
Continue taking the medication even if you feel well; do not stop without medical advice.
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose; do not double up on doses.
Lifestyle Advice
Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins.
Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise per week.
Monitor blood sugar levels regularly to track your response to the medication.
Avoid excessive alcohol consumption, as it can affect blood sugar levels.
Stay hydrated by drinking plenty of water throughout the day.
Work with a healthcare provider to develop a personalized diabetes management plan.
Side Effects
Common side effects include nausea, vomiting, diarrhea, and abdominal discomfort.
Some patients may experience headaches or dizziness.
Serious side effects can include lactic acidosis, which is a rare but serious condition requiring immediate medical attention.
If you experience symptoms like unusual tiredness, muscle pain, or difficulty breathing, seek medical help promptly.
Allergic reactions such as rash, itching, or swelling may occur; discontinue use and consult a doctor if these happen.
Precautions and Warnings
Do not use Trajenta Duo 2.5/850 mg Tablet if you have severe kidney impairment or are on dialysis.
Consult your doctor if you have a history of pancreatitis or liver disease.
Avoid alcohol while taking this medication due to the risk of lactic acidosis.
Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before use.
Monitor kidney function regularly during treatment, especially in older adults or those with existing kidney issues.
If you experience symptoms of low blood sugar (hypoglycemia), such as sweating, shaking, or confusion, seek medical advice immediately.
1. Is Trajenta Duo 2.5/850 mg Tablet safe for everyone? Trajenta Duo 2.5/850 mg Tablet is not suitable for individuals with type 1 diabetes or those with a history of severe kidney problems.
2. What should I do if I miss a dose? If you miss a dose of Trajenta Duo 2.5/850 mg Tablet, take it as soon as you remember unless it's close to your next scheduled dose.
3. Can I take Trajenta Duo 2.5/850 mg Tablet with other medications? Always inform your healthcare provider about all medications you are taking, as some may interact with Trajenta Duo 2.5/850 mg Tablet.
4. How should I store Trajenta Duo 2.5/850 mg Tablet? Store Trajenta Duo 2.5/850 mg Tablet at room temperature away from moisture and heat.
5. What are the common side effects? Common side effects may include gastrointestinal disturbances such as nausea or diarrhea.
6. Can pregnant women use Trajenta Duo 2.5/850 mg Tablet? Pregnant women should consult their healthcare provider before using Trajenta Duo 2.5/850 mg Tablet.
7. Is it safe to drive while taking this medication? Trajenta Duo 2.5/850 mg Tablet does not typically impair driving ability, but monitor how you feel before driving.
No content available for this section.
SKU
822009
Country of Manufacture
India
Manufacturer Address
Boehringer Ingelheim India Pvt. Ltd.
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Seller
Kogland Commerce Pvt Ltd (TN)
Trajenta Duo 2.5/850 mg Tablet is a prescription medication specifically designed for the management of type 2 diabetes mellitus. This pharmaceutical product combines two active ingredients: Linagliptin and Metformin. Linagliptin is a DPP-4 inhibitor that works by increasing the levels of incretin hormones, which in turn helps to regulate blood sugar levels by stimulating insulin secretion and reducing glucagon secretion. Metformin, on the other hand, is a biguanide that primarily decreases hepatic glucose production and enhances insulin sensitivity in peripheral tissues. The combination of these two agents in Trajenta Duo 2.5/850 mg Tablet provides a synergistic effect, making it an effective option for patients who require better glycemic control. The tablet is typically prescribed when diet and exercise alone have not been sufficient to control blood sugar levels. It is important to note that Trajenta Duo 2.5/850 mg Tablet is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis. The formulation is available in a convenient tablet form, allowing for easy administration and adherence to treatment regimens. Patients using Trajenta Duo 2.5/850 mg Tablet should be monitored regularly for efficacy and safety, as with any diabetes medication, to ensure optimal management of their condition.
Uses & Benefits
Helps in controlling blood sugar levels in adults with type 2 diabetes.
Reduces the risk of diabetes-related complications.
Improves glycemic control when used alongside diet and exercise.
Combines the benefits of Linagliptin and Metformin for enhanced efficacy.
May lead to weight stabilization or modest weight loss compared to other diabetes medications.
Can be used in conjunction with other antidiabetic medications if needed.
How Trajenta Duo 2.5/850 mg Tablet works
Linagliptin increases incretin levels, leading to increased insulin secretion from the pancreas.
It decreases glucagon secretion, which reduces glucose production by the liver.
Metformin decreases hepatic glucose output and enhances insulin sensitivity in muscle and fat tissues.
The combination helps to lower blood glucose levels effectively.
Both components work together to provide better overall glycemic control.
How to use Trajenta Duo 2.5/850 mg Tablet
Take Trajenta Duo 2.5/850 mg Tablet orally with or without food, as directed by your healthcare provider.
The usual starting dose is one tablet taken once daily.
Dosage may be adjusted based on individual response and blood glucose levels.
Do not exceed the prescribed dosage without consulting your doctor.
Continue taking the medication even if you feel well; do not stop without medical advice.
If you miss a dose, take it as soon as you remember unless it's almost time for your next dose; do not double up on doses.
Lifestyle Advice
Maintain a balanced diet rich in whole grains, fruits, vegetables, and lean proteins.
Engage in regular physical activity, aiming for at least 150 minutes of moderate exercise per week.
Monitor blood sugar levels regularly to track your response to the medication.
Avoid excessive alcohol consumption, as it can affect blood sugar levels.
Stay hydrated by drinking plenty of water throughout the day.
Work with a healthcare provider to develop a personalized diabetes management plan.
Side Effects
Common side effects include nausea, vomiting, diarrhea, and abdominal discomfort.
Some patients may experience headaches or dizziness.
Serious side effects can include lactic acidosis, which is a rare but serious condition requiring immediate medical attention.
If you experience symptoms like unusual tiredness, muscle pain, or difficulty breathing, seek medical help promptly.
Allergic reactions such as rash, itching, or swelling may occur; discontinue use and consult a doctor if these happen.
Precautions and Warnings
Do not use Trajenta Duo 2.5/850 mg Tablet if you have severe kidney impairment or are on dialysis.
Consult your doctor if you have a history of pancreatitis or liver disease.
Avoid alcohol while taking this medication due to the risk of lactic acidosis.
Pregnant or breastfeeding women should discuss potential risks with their healthcare provider before use.
Monitor kidney function regularly during treatment, especially in older adults or those with existing kidney issues.
If you experience symptoms of low blood sugar (hypoglycemia), such as sweating, shaking, or confusion, seek medical advice immediately.
1. Is Trajenta Duo 2.5/850 mg Tablet safe for everyone? Trajenta Duo 2.5/850 mg Tablet is not suitable for individuals with type 1 diabetes or those with a history of severe kidney problems.
2. What should I do if I miss a dose? If you miss a dose of Trajenta Duo 2.5/850 mg Tablet, take it as soon as you remember unless it's close to your next scheduled dose.
3. Can I take Trajenta Duo 2.5/850 mg Tablet with other medications? Always inform your healthcare provider about all medications you are taking, as some may interact with Trajenta Duo 2.5/850 mg Tablet.
4. How should I store Trajenta Duo 2.5/850 mg Tablet? Store Trajenta Duo 2.5/850 mg Tablet at room temperature away from moisture and heat.
5. What are the common side effects? Common side effects may include gastrointestinal disturbances such as nausea or diarrhea.
6. Can pregnant women use Trajenta Duo 2.5/850 mg Tablet? Pregnant women should consult their healthcare provider before using Trajenta Duo 2.5/850 mg Tablet.
7. Is it safe to drive while taking this medication? Trajenta Duo 2.5/850 mg Tablet does not typically impair driving ability, but monitor how you feel before driving.
No content available for this section.
SKU
822009
Country of Manufacture
India
Manufacturer Address
Boehringer Ingelheim India Pvt. Ltd.
Return/Buy Back policy
Non-returnable
Prescription Required
Yes
Seller
Kogland Commerce Pvt Ltd (TN)
Door Step Delivery
Quick and Secure
No Hidden Charges
Pay only what's shown
18K Pincodes Served
With Trust & Reliability
Related Products
Customer Reviews
No reviews yet
Be the first to share your thoughts. Honest feedback helps other shoppers and us serve you better.
